"Jefferies pulls from an audit of a partnership between IBM Watson and MD Anderson as a case study for IBM’s broader problems scaling Watson. MD Anderson cut its ties with IBM after wasting $60 million on a Watson project that was ultimately deemed, “not ready for human investigational or clinical use.”Jefferies gives IBM Watson a Wall Street reality check | TechCrunch
The MD Anderson nightmare doesn’t stand on its own. I regularly hear from startup founders in the AI space that their own financial services and biotech clients have had similar experiences working with IBM.
The narrative isn’t the product of any single malfunction, but rather the result of overhyped marketing, deficiencies in operating with deep learning and GPUs and intensive data preparation demands."
Monday, July 17, 2017
Jefferies gives IBM Watson a Wall Street reality check | TechCrunch
Also see IBM's Watson gets no love on Wall Street (Axios)